跳至主要内容
临床试验/NCT01902836
NCT01902836已完成2 期

Efficacy of Human Dialyzed Leukocytes Extracts in Paediatrics Patients With Moderate Atopic Dermatitis.

National Polytechnic Institute, Mexico2 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2011年8月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
58
试验地点
2
主要终点
Clinical outcome evaluated by SCORAD

研究概览

简要总结

Patients with atopic dermatitis treated with conventional treatment plus Dialyzed Leukocyte Extracts (DLE-oral Transferon) as adjuvant, have better clinical outcome than patients treated only with conventional treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
2 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Atopic dermatitis diagnosis by Hanifin and Rajka classification
  • Dermatitis severity: Moderate, according with SCORAD index.
  • Patients without treatment of topical steroids or immunosuppressants in the last 3 weeks.
  • Patients with "informed consent form" signed by both parents, or advisor.
  • Patients 7 years old or older whom have signed the assent form

排除标准

  • Patient who were treated with topical, or systemic steroids and/or immunosuppressants and they cannot discontinue their treatment.
  • Patients who lived far from the hospital and they could not go to the visits.

结局指标

主要结局

Clinical outcome evaluated by SCORAD

时间窗: Day 14

To determine clinical outcome by SCORAD.

次要结局

  • Immunophenotypical changes induced by adjuvant treatment (DLE) (oral Transferon)(28 days)

研究者

发起方
National Polytechnic Institute, Mexico
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria C Jimenez Martinez

PhD

Instituto de Oftalmología Fundación Conde de Valenciana

研究点 (2)

Loading locations...

相似试验